Serum Amyloid A as a Biomarker for Radiation Exposure

Radiation Research

Volumn 184, Issue 1, 2015, Pages 14-23

  Sproull, Mary ^a   Kramp, Tamalee ^a   Tandle, Anita ^a   Shankavaram, Uma ^a   Camphausen, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; SERUM AMYLOID A; GAMMA-H2AX PROTEIN, MOUSE; HISTONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; DOSIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; WESTERN BLOTTING; WHOLE BODY RADIATION; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; INFLAMMATION; PROCEDURES; RADIATION MONITORING;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE; FEMALE; HISTONES; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; RADIATION MONITORING; SERUM AMYLOID A PROTEIN; WHOLE-BODY IRRADIATION;

EID: 84942627040     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR13927.1     Document Type: Article

References (43)

1. Ivey RG, Subramanian O, Lorentzen TD, Paulovich AG. Antibody-based screen for ionizing radiation-dependent changes in the mammalian proteome for use in biodosimetry. Radiat Res 2009; 171:549-61.
2. Pandey BN, Kumar A, Tiwari P, Mishra KP. Radiobiological basis in management of accidental radiation exposure. Int J Radiat Biol 2010; 86:613-35.
3. Van der Meeren A, Monti P, Lebaron-Jacobs L, Marquette C, Gourmelon P. Characterization of the acute inflammatory response after irradiation in mice and its regulation by interleukin 4 (Il4). Radiat Res 2001; 155:858-65.
4. Ossetrova NI, Sandgren DJ, Blakely WF. C-reactive protein and serum amyloid A as early-phase and prognostic indicators of acute radiation exposure in nonhuman primate total-body irradiation model. Radiat Measure 2011; 46:1019-24.
5. Kim D, Marchetti F, Chen Z, Zaric S, Wilson RJ, Hall DA, et al. Nanosensor dosimetry of mouse blood proteins after exposure to ionizing radiation. Sci Reports 2013; 3:2234.
6. Chait A, Han CY, Oram JF, Heinecke JW. Thematic review series: The immune system and atherogenesis. lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J Lipid Res 2005; 46:389-403.
7. Petersen HH, Nielsen JP, Heegaard PM. Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res 2004; 35:163-87.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54.
9. Jensen LE, Whitehead AS. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 1998; 334 (Pt. 3):489-503.
10. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999; 265:501-23.
11. Ossetrova NI, Condliffe DP, Ney PH, Krasnopolsky K, Hieber KP, Rahman A, et al. Early-response biomarkers for assessment of radiation exposure in a mouse total-body irradiation model. Health Phys 2014; 106:772-86.
12. Avondoglio D, Scott T, Kil WJ, Sproull M, Tofilon PJ, Camphausen K. High throughput evaluation of gamma-H2AX. Radiat Oncol 2009; 4:31.
13. Okunieff P, Chen Y, Maguire DJ, Huser AK. Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev 2008; 27:363-74.
14. Prasanna PG, Blakely WF, Bertho JM, Chute JP, Cohen EP, Goans RE, et al. Synopsis of partial-body radiation diagnostic biomarkers and medical management of radiation injury workshop. Radiat Res 2010; 173:245-53.
15. Rothkamm K, Horn S. gamma-H2AX as protein biomarker for radiation exposure. Ann Ist Super Sanita 2009; 45, 265-71.
16. Redon CE, Dickey JS, Bonner WM, Sedelnikova OA. gamma-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin. Adv Space Res 2009; 43:1171-8.
17. Marchetti F, Coleman MA, Jones IM, Wyrobek AJ. Candidate protein biodosimeters of human exposure to ionizing radiation. Int J Radiat Biol 2006; 82:605-39.
18. Ossetrova NI, Sandgren DJ, Gallego S, Blakely WF. Combined approach of hematological biomarkers and plasma protein SAA for improvement of radiation dose assessment triage in biodosimetry applications. Health Phys 2010; 98:204-8.
19. Ossetrova NI, Blakely WF. Multiple blood-proteins approach for early-response exposure assessment using an in vivo murine radiation model. Int J Radiat Biol 2009; 85:837-50.
20. Ossetrova NI, Sandgren DJ, Blakely WF. Protein biomarkers for enhancement of radiation dose and injury assessment in nonhuman primate total-body irradiation model. Radiat Prot Dosimetry 2014; 159:61-76.
21. Blakely WF, Sandgren DJ, Nagy V, Kim S-Y, Sigal GB, Ossetrova NI. Further biodosimetry investigations using murine partial-body irradiation model. Radiat Prot Dosimetry 2014; 159:46-51.
22. Blakely W, Sandgren DJ, Nagy V, Kim SY, Ossetrova, NI. Murine partial-body radiation exposure model for biodosimetry studies-Premilinary Report. Radiat Measure 2011; 46:898-902.
23. Bentzen SM, Parliament M, Deasy JO, Dicker A, Curran WJ, Williams JP, et al. Biomarkers and surrogate endpoints for normaltissue effects of radiation therapy: The importance of dose-volume effects. Int J Radiat Oncol Biol Phys 2010; 76:S145-50.
24. Coleman CN, Adams S, Adrianopoli C, Ansari A, Bader JL, Buddemeier B, et al. Medical planning and response for a nuclear detonation: A practical guide. Biosecur Bioterror 2012; 10:346-71.
25. Bertho JM, Roy L, Souidi M, Benderitter M, Bey E, Racine R, et al. Initial evaluation and follow-up of acute radiation syndrome in two patients from the Dakar accident. Biomarkers 2009; 14:94-102.
26. Bertho JM, Roy L, Souidi M, Benderitter M, Gueguen Y, Lataillade JJ, et al. New biological indicators to evaluate and monitor radiation-induced damage: An accident case report. Radiat Res 2008; 169:543-50.
27. Waller E, Millage K, Blakely WF, Ross JA, Mercier JR, Sandgren DJ, et al. Overview of hazard assessment and emergency planning software of use to RN first responders. Health Phys 2009; 97:145-56.
28. Gourmelon P, Benderitter M, Bertho JM, Huet C, Gorin NC, De Revel P. European consensus on the medical management of acute radiation syndrome and analysis of the radiation accidents in Belgium and Senegal. Health Phys 2010; 98:825-32.
29. Flood AB, Nicolalde RJ, Demidenko E, Williams BB, Shapiro A, Wiley AL, Jr., et al. A framework for comparative evaluation of dosimetric methods to triage a large population following a radiological event. Radiat Measure 2011; 46:916-22.
30. Takata S, Wada H, Tamura M, Koide T, Higaki M, Mikura SI, et al. Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times. Biomarkers 2011; 16:530-5.
31. Goltry KL, Epperly MW, Greenberger JS. Induction of serum amyloid A inflammatory response genes in irradiated bone marrow cells. Radiat Res 1998; 149:570-8.
32. Ogata T, Yamazaki H, Teshima T, Kihara A, Suzumoto Y, Inoue T, et al. Early administration of IL-6RA does not prevent radiationinduced lung injury in mice. Radiat Oncol 2010; 5:26.
33. Bertho JM, Griffiths NM, Gourmelon P. The medical diagnosis and treatment of radiation overexposed people (RC-7a). 11th Congress of the International Radiation Protection Association; Madrid, Spain. 2004. (http://bit. ly/1AgUz4X)
34. Dainiak N, Berger P, Albanese J. Relevance and feasibility of multi-parameter assessment for management of mass casualties from a radiological event. Exp Hematol 2007; 35:17-23.
35. Pierce BL, Neuhouser ML, Wener MH, Bernstein L, Baumgartner RN, Ballard-Barbash R, et al. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat 2009; 114:155-67.
36. Sasazuki S, Inoue M, Sawada N, Iwasaki M, Shimazu T, Yamaji T, et al. Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case-control study: Japan Public Health Center-based prospective study. Carcinogenesis 2010; 31:712-8.
37. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109:726-32.
38. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996; 26:427-35.
39. Kokubun M, Imafuku Y, Okada M, Ohguchi Y, Ashikawa T, Yamada T, et al. Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio. Clin Chim Acta 2005; 360:97-102.
40. Migita K, Abiru S, Nakamura M, Komori A, Yoshida Y, Yokoyama T, et al. Lipopolysaccharide signaling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitro. FEBS Lett 2004; 569:235-9.
41. Flynn DF, Goans RE. Nuclear terrorism: Triage and medical management of radiation and combined-injury casualties. Surg Clin North Am 2006; 86:601-36.
42. Koenig KL, Goans RE, Hatchett RJ, Mettler FA, Jr., Schumacher TA, Noji EK, et al. Medical treatment of radiological casualties: current concepts. Ann Emer Med 2005; 45:643-52.
43. Sproull M, Avondoglio D, Kramp T, Shankavaram U, Camphausen K. Correlation of plasma FL expression with bone marrow irradiation dose. PloS One 2013; 8:e58558.